OcuSeal
Commercial- Indications
- Ocular tissue repair, Corneal abrasions, Cataract incisions, Sclerotomy incisions
Company intelligence / Profile preview
HyperBranch developed and commercialized hydrogel-based surgical sealants for use in neurosurgery and ophthalmology. Its lead products—Adherus AutoSpray Dural Sealant and OcuSeal liquid ocular bandage—demonstrated clinical safety and efficacy as adjuncts to standard surgical closure methods. Adherus AutoSpray became one of only two FDA-approved dural sealants on the U.S. market[2][1][8].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HyperBranch Medical Technology.